Virus Control in Vaccinated Rhesus Macaques Is Associated with Neutralizing and Capturing Antibodies against the SHIV Challenge Virus but Not with V1V2 Vaccine-Induced Anti-V2 Antibodies Alone.
AIDS Vaccines
/ administration & dosage
Animals
Antibodies, Neutralizing
/ blood
Antibodies, Viral
/ blood
Antibody-Dependent Cell Cytotoxicity
/ immunology
Disease Models, Animal
Female
Gene Products, env
/ immunology
HIV Infections
/ blood
Humans
Immunogenicity, Vaccine
Macaca mulatta
Male
Phagocytosis
/ immunology
Simian Acquired Immunodeficiency Syndrome
/ blood
Simian Immunodeficiency Virus
/ immunology
Viral Load
Journal
Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R
Informations de publication
Date de publication:
15 03 2021
15 03 2021
Historique:
received:
01
09
2020
accepted:
04
01
2021
pubmed:
5
2
2021
medline:
6
8
2021
entrez:
4
2
2021
Statut:
ppublish
Résumé
The role of vaccine-induced anti-V2 Abs was tested in three protection experiments in rhesus macaques. In an experiment using immunogens similar to those in the RV144 vaccine trial (Anti-envelope [Env]), nine rhesus macaques were coimmunized with gp160
Identifiants
pubmed: 33536254
pii: jimmunol.2001010
doi: 10.4049/jimmunol.2001010
pmc: PMC7946713
mid: NIHMS1661248
doi:
Substances chimiques
AIDS Vaccines
0
Antibodies, Neutralizing
0
Antibodies, Viral
0
Gene Products, env
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1266-1283Subventions
Organisme : NIAID NIH HHS
ID : HHSN272201800007C
Pays : United States
Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI112546
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118581
Pays : United States
Informations de copyright
Copyright © 2021 by The American Association of Immunologists, Inc.
Références
Nature. 2011 May 26;473(7348):523-7
pubmed: 21562493
Mol Biol Evol. 2011 Oct;28(10):2731-9
pubmed: 21546353
Immunity. 2019 Jan 15;50(1):241-252.e6
pubmed: 30552025
J Med Primatol. 2005 Oct;34(5-6):303-12
pubmed: 16128925
J Virol. 2016 Nov 28;90(24):11007-11019
pubmed: 27707920
Vaccine. 2016 May 23;34(24):2713-21
pubmed: 27102818
PLoS One. 2012;7(6):e39045
pubmed: 22720026
Hum Vaccin Immunother. 2020 Sep 1;16(9):2033-2041
pubmed: 32701369
J Virol. 2007 Dec;81(23):13037-49
pubmed: 17855534
Lancet. 2018 Jul 21;392(10143):232-243
pubmed: 30047376
Proc Natl Acad Sci U S A. 2009 Dec 8;106(49):20877-82
pubmed: 19933330
J Virol. 2016 Sep 12;90(19):8487-95
pubmed: 27440881
J Immunol. 2002 Sep 15;169(6):3438-46
pubmed: 12218167
Virology. 2019 Mar;529:57-64
pubmed: 30665098
J Virol. 2018 May 14;92(11):
pubmed: 29514914
J Virol. 2015 Apr;89(8):4690-5
pubmed: 25653428
Sci Rep. 2017 Oct 4;7(1):12655
pubmed: 28978939
J Virol. 2015 Aug;89(16):8643-50
pubmed: 26018159
PLoS Pathog. 2018 Aug 28;14(8):e1007278
pubmed: 30153309
Science. 2020 Feb 7;367(6478):611-612
pubmed: 32029605
J Virol. 2016 Nov 28;90(24):10993-11006
pubmed: 27630234
Genes Immun. 2008 Jan;9(1):69-80
pubmed: 18094710
Nature. 2012 Jan 04;482(7383):89-93
pubmed: 22217938
Sci Transl Med. 2019 Sep 11;11(509):
pubmed: 31488581
Nat Commun. 2017 Jun 08;8:15711
pubmed: 28593989
J Virol. 2009 Jan;83(2):662-72
pubmed: 18987151
Immunity. 2013 Jan 24;38(1):176-86
pubmed: 23313589
J Virol. 2008 Apr;82(8):3952-70
pubmed: 18256145
J Immunol. 2016 Oct 1;197(7):2726-37
pubmed: 27591322
J Virol. 2013 Feb;87(3):1554-68
pubmed: 23175357
J Bacteriol. 2005 Dec;187(24):8370-4
pubmed: 16321941
Nat Med. 2016 Jul;22(7):762-70
pubmed: 27239761
J Immunol Methods. 2011 Mar 7;366(1-2):8-19
pubmed: 21192942
N Engl J Med. 2012 Apr 5;366(14):1275-86
pubmed: 22475592
Science. 2019 Sep 6;365(6457):1029-1033
pubmed: 31488689
Mucosal Immunol. 2014 Jan;7(1):46-56
pubmed: 23591718
PLoS One. 2017 Mar 13;12(3):e0173705
pubmed: 28288209
Science. 2019 Sep 6;365(6457):1025-1029
pubmed: 31488688
Nature. 2011 Nov 23;480(7377):336-43
pubmed: 22113616
Nat Med. 2018 Jun;24(6):847-856
pubmed: 29785023
J Virol. 2017 Mar 29;91(8):
pubmed: 28122974
J Virol. 2013 Feb;87(3):1708-19
pubmed: 23175374
PLoS One. 2013 Jul 23;8(7):e69406
pubmed: 23936006
Nat Immunol. 2008 Mar;9(3):301-9
pubmed: 18264102
J Virol. 2000 Aug;74(15):7096-107
pubmed: 10888650
Cell Host Microbe. 2011 May 19;9(5):355-61
pubmed: 21575907
J Clin Invest. 2019 Mar 1;129(3):1314-1328
pubmed: 30776026
Immunol Rev. 2017 Jan;275(1):245-261
pubmed: 28133811
Mol Immunol. 2015 Aug;66(2):364-74
pubmed: 25965315
Nature. 2012 Oct 18;490(7420):417-20
pubmed: 22960785
J Virol. 2012 Nov;86(22):12039-52
pubmed: 22933282
J Virol. 1994 Dec;68(12):8312-20
pubmed: 7525987
J Immunol. 2014 Dec 15;193(12):6172-83
pubmed: 25398324
Science. 2019 Sep 6;365(6457):1033-1036
pubmed: 31488690
Cell Rep. 2019 Jul 23;28(4):877-895.e6
pubmed: 31340151
PLoS One. 2010 Jan 20;5(1):e8805
pubmed: 20098712
Proc Natl Acad Sci U S A. 2011 Jul 5;108(27):11181-6
pubmed: 21690411
J Virol. 2005 Aug;79(16):10108-25
pubmed: 16051804
J Virol. 2014 Nov;88(22):12949-67
pubmed: 25210191
J Virol. 2018 Jul 17;92(15):
pubmed: 29793957
Virology. 2012 Jun 5;427(2):198-207
pubmed: 22402248
Science. 2015 Jul 17;349(6245):320-4
pubmed: 26138104
J Virol. 2006 May;80(10):5074-7
pubmed: 16641299
Vaccine. 2012 Aug 10;30(37):5519-26
pubmed: 22749601
Vaccines (Basel). 2019 Aug 06;7(3):
pubmed: 31390725
J Virol. 2018 Jan 2;92(2):
pubmed: 29093095
PLoS Pathog. 2015 Aug 03;11(8):e1005042
pubmed: 26237403
Cell. 2013 Oct 24;155(3):531-9
pubmed: 24243013
PLoS One. 2017 Nov 17;12(11):e0185959
pubmed: 29149197